Health Care & Life Sciences » Biotechnology | Voyager Therapeutics Inc.

Voyager Therapeutics Inc.

Voyager Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
32.44 M
Public Float
18.44 M
Voyager Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.94
Market Cap
$1.01 B
Shares Outstanding
36.83 M
Public Float
20.17 M

Profile

Address
75 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.voyagertherapeutics.com
Updated 07/08/2019
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A.

Financials

View All

Mark Jay Levin
Chairman
G. Andre Turenne
President, Chief Executive Officer & Director